Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted January 18, 2003
Non-Prescription Anti-Hypertension Pills Recalled
On January 17, the U.S. FDA's MedWatch Program reported that Herbsland Inc. recalled all 100 tablet bottles of Ancom Anti-Hypertensive Compound Tablets, an unapproved new drug labeled to contain several prescription drug ingredients, including reserpine, diazepam, promethiazine, and hydrochlorothiazide. The sale of a product with this combination of ingredients poses possible serious health risks including sedation, depression, and potentially life-threatening abnormalities of the blood. This recall includes all lot codes of the product remaining on the market. Ancom Tablets were sold without prescriptions to consumers through distributors and retail stores located in the New York City metropolitan area, specifically Manhattan, Brooklyn, and Queens. Nationwide sales are also possible as this product was sold via the Internet
Join today to unlock all member benefits including full access to all recalls & warningsJoin Now
Already a member? Sign In Here.
Join now at www.consumerlab.com/join/